The integration of artificial intelligence (AI) in healthcare is rapidly advancing, promising significant improvements in patient care and operational efficiency. Nonetheless, as this technological leap transforms medical practices, it also raises critical ethical considerations, particularly
Alzheimer’s disease (AD) is a progressive neurodegenerative condition that significantly impacts memory, cognition, and behavior. Early detection is crucial for effective intervention, especially with the development of new anti-amyloid therapies. However, traditional diagnostic tools face a
The PROSPECT-Lung trial has officially commenced, heralding a significant advance in the quest to enhance treatment strategies for patients with resectable non-small cell lung cancer (NSCLC). This trial marks the inaugural endeavor of the newly established National Cancer Institute (NCI) Clinical
The article "Leveraging RWD With AI To Enable Diverse Recruitment In Clinical Trials" by Lakshmi Sankar and Isabelle Cheung explores the importance and challenges of enhancing diversity within clinical trials, particularly in terms of recruiting participants from underrepresented
Respiratory Syncytial Virus (RSV) is a common virus that infects nearly all children by the age of two, but while most cases are mild, some children experience severe respiratory illness that requires hospitalization. The mechanisms behind this severity, especially the role and dysfunction of
The emergence of highly pathogenic avian influenza (HPAI) H5N1 in 1996 marked a significant event in the history of infectious diseases. Over the years, this virus has spread across continents, infecting various species and creating diverse clades. The potential for H5N1 to adapt to humans through
Drug addiction has been a persistent issue throughout human history, documented from ancient times. Traditionally viewed as a moral failing rather than a treatable disease, the perception of addiction began to shift in the 20th century with scientific discoveries highlighting its basis in brain
In a remarkable breakthrough in breast cancer treatment, a novel cell-based immunotherapy developed by Dr. Gary Koski from Kent State University and Dr. Brian J. Czerniecki from the Moffitt Cancer Center has been recently accepted for publication in JAMA Oncology. This innovative approach harnesses
Earlier this week, the U.S. Food and Drug Administration (FDA) unveiled its much-anticipated final guidance on predetermined change control plans (PCCPs) for devices incorporating artificial intelligence and machine learning (AI/ML) software. This guidance signifies a significant milestone in the
For lymphoma patients, particularly those facing relapsed or refractory large B cell lymphoma (LBCL), CAR T cell therapy represents a beacon of hope. This promising treatment, epitomized by Breyanzi (lisocabtagene maraleucel), offers a new avenue for those who have exhausted conventional treatment
